Objectives: This contribution providesaunifyingconcept formeta-analysis integrating the handlingofunobserved heterogeneity,study covariates, publication bias andstudy quality. It is importanttoconsiderthese issues simultaneously to avoid the occurrenceofartifacts, andamethodfor doingsoissuggested here. Methods: The approach is basedupon themetalikelihood in combination with a general linear nonparametric mixed model, which lays thegroundfor all inferential conclusions suggested here. Results: Theconcept is illustrated at hand of ametaanalysis investigatingthe relationship of hormonereplacement therapy andbreastcancer. Thephenomenon of interest has been investigated in manystudies for a considerabletime anddifferent resultswerereported. In 1992 ameta-analysis by Sillero-Arenasetal.
Introductionand Background
In alle mpirical sciences there exists an enormous body of empiricalknowledge for agiven question of interest.This knowledge haso ftenb een collected in numerous studies ande mpirical investigationsb y meanso fe xperimentals tudies, clinical trials or observational studies.T ypically, these individual findings areb uried in the scientific literature, in registries, or some other formo fd ocumentary source. From here,theymustberetrievedand relevant information extracted,and finally, statistically analyzed by an appropriatem ethodology. We have enteredthe territoryof meta-analysis. Numerous publicationsi nt he area underline that meta-analysish as become a centralr ole in the collection,a nalysisa nd evaluation of findings in anye mpirical science. Beforew ep roceed to develop a generals tatistical framework for coping with controversial issues in amore universal framework, we hope to initiateinterest in the question by recalling arecentdebateonthe publichealth issueofhormone replacement therapy.H ormone replacementt herapy is applied to achieve positiveeffectsinmany respects for womenn ear anda fterm enopause. It hasbeen questioned,however,for a longerperiod if it relatestothe occurrence of breast cancer.
In ar ecente vening news broadcast Die Tagesthemen a the following eventw as reported whicht ranslatesa sf ollows: "New Doubts on Hormone Replacement Therapy. Due to arising carefor the participating womenahormone study (the WHI-study) in the USA including 16,000 older womenwas terminatede arliert hans cheduled. Theo bjective of the study wast oi nvestigatet he benefito fO estrogenesa nd Progestinesfor femalesinoraftermenopause. As it turned out that the risksoccurring duetothe daily dosages of hormone arelargerthantheir potential benefits,t he US health administration NIHd eclared termination of the study three yearsprior to the endofthe designeds tudyp eriod.S pecifically,m ore cases of breast cancer,m yocardial infarction,stroke,and blood clothing in the lung hado ccurred in the exposed group (under hormone treatment) thani nt he control group (no exposure)w hich wasg iven a placebopresumingly of no effect." (Die Tagesthemen, ARD10:30 p.m.). Details of the before mentioned study can be found elsewhere [2] . Forbreast cancer the study provided ariskratio of 1.26.This seems to be a minore ffect.H owever,o ne should keep in mind thatevenasmallelevatedrelativerisk can have largep ublich ealth effectsi ft he size of the exposed population is large.T o demonstrate let us assume thati napopulation with abaseline riskofbreast cancer of 1in100 there are1,000,000 underhormone replacementtherapy (HRT)leading to 2,600 additional cases due to HRT(using the risk ratio of the abovem entioned study). Even with adiminishedassumptionof1in1000 (the baseline riske.g.the risk in the placebo armofthe WHI-study was, with 124breast cancer cases in 8,102women underrisk, far abovethis number [2] )one can expect about 260 additional cases due to HRT. Thus,even smalleffectsare of considerableimportance a This eveningn ewsb elongs to Channel One of publicG erman television and has typicallyl eading participantquota.
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when the exposure is widespread in the community.
This finding of the WHI-study hasn ot onlybeen takenupb ythe media as important health news, even medical investigators executing clinical trials with ahormone replacementt herapy armw eret aken by surprise by the results of the WHI-trial (see Fig. 1 ). In thisc ase, am edical study was publiclycriticized for using HRT, thoughit would have been known that an excess risk for developing breast cancer exists.Interestingly,i ni ts responset he medical team pointed out that theyw ould have not executedthe trial in thisfashion if the excess riskshad been known prior to the time of the beginning of their study.I na ddition, the medical team pointed the attentiono ft he reader to the agreemento ft he hospital's ethicalc ommittee.H owever,a sw ew ill argue in thisc ontribution, appropriate analysis of the body of evidencewould have flaggeds ources of excess risksac onsiderable time earlier.
Indeed,ifwereconsider the meta-analysisb yS illero-Arenase ta l. [1] a nd uset he appropriatet ools in as econdary analysis, we find an estimate of 1.137onthe relative risk scale. This finding occurs sincet he meta-analysisathandexperiences considerable unobservedh eterogeneity, whichh as previouslyb een ignored (leading to ad iminishedeffect estimate of 1.06). We argue further in thiscontribution that thisformof heterogeneitycan be successfullylinked to covariateso bservedi nt he study base provided by SA, namelythe study type (cohort or case-control) andwhether in the study the estimate of effect hasbeen adjustedfor potential confounders. It can be furthermore establishedt hatt hese covariatesc orrelate with the size of the effect measure.C onsequently,a no dds ratioa djustedf or study type andconfoundertreatment seems to be morea ppropriate, leading to the oneg iven above.
In this contribution, we outline ageneral conceptb ased on what is called the metalikelihood, whichp rovidesau nifying approach to deal with severaltypicalproblems in the area of meta-analysis: study covariates and unobserved heterogeneity,p ublication bias and study quality.
An Application: TheDataof theMeta-AnalysisofHormone ReplacementTherapy and the Occurrence of Breast Cancer
We would like to come back to am etaanalysis provided by Sillero-Arenase ta l.
[1]-t hroughout thisp aper abbreviateda s SA -and point out that the finding of the recenttrial [2] is not surprising andessentially agrees with the result of the meta-analysis. Them eta-analysis [1] contained2 3c asecontrol studies and13cohortstudies. There wasalsoone clinical trialmentioned thatis not further consideredh eres incer elevant information could not be retrievedf or this study.
2.1E ffect Measure and 95% Confidence Interval
Sincethere is amixture of study designs the odds ratioappearstobethe appropriateeffect measure.The odds ratioi sv alidlye stimablei nc ase-control and cohorts tudies, whereas the relative risk can onlybevalidly estimatedincohortstudies, thoughthe dif- Meta-Analysis: aUnifyingMeta-Likelihood Approach ferences between the twoare smallwhenthe baseline-riskissmall.Therefore,odds ratios might be interpretable as relative risks. Odds ratios were availablei nt he original meta-analysisa nd were providedw ith 95%confidenceintervals (see Table1).
2.2S tandardError
In the originalm eta-analysis the standard errors associated with the log-odds ratios were not available. However, theycan easily be reconstructed sincethe 95% C.I. is constructed as log(OR) ± 1.96 SE,w here SE is the standard error for the log(OR). Let the twoi ntervale nds be denoted by Ua nd L, then the standard error is found as SE =(U-L)/(1.96 × 2). This formula was used to constructt he data provided in column 3ofTable 2.
2.3S ample Size
Sample sizes were also provided in the original meta-analysis, buto nd ifferent scales (numberofpersons for case-control studies andn umber of person-yearsf or cohort studies). Sincethe sample size is relatedinverselyt ot he standard error we will use 1/SE as as ubstitutef or the sample size wherever this is needed.
2.4D ate of Data Collection
Formoststudiesatime forthe data collection is providedaswell. If atime interval is given, we have used the mid-point.
2.5S tudy Type
Twos tudyt ypesa re used:c ohort( 13 studies)and case-control (23 studies). This information will be utilized andconsidered as apotential sourceofbias. 
2.6N umberofCovariatesAdjusted for
When doing observational studies it is important to control for potential confounding covariatesl ikea ge,B MI,e tc.T his information wasa vailablei nt he original meta-analysisand will also be consideredas apotential sourceofbias. Allthese covariates areprovidedinTable 1.
StatisticalMethodsAn Approach Basedupon the Meta-Likelihood 3.1T he Meta-Likelihood
Meta-analysis hasbecome astandardtool in medical research.Recently, anumber of excellent bookshaveappeared [3] [4] [5] [6] updating an umber of earlierc ontributions [7] [8] [9] . In addition, special texts have appeared dealing with Bayesian approaches [10] or heterogeneity modeling [11] .Inthe following, alikelihood approach is used whichappears to be widelyaccepted.
It is assumed thatt he effect measure λ^i for the i-th study (inthe application it is the log-odds ratio) follows (atl east approximately)anormal distribution with density of λ^i : (1) where λ i is the unknown effect measure in study iand σ i 2 is the known study variance (see column 3o fT able 2).H aving ki ndependent studies availablet his leads to the meta-likelihood (2) whichw ill be the basisf or alli nferential conclusions. Nowd ifferent modelsf or the effect measure λ i can be considered. .This is also calledthe pooled or fixed effect estimate.Itisparticularlyattractivesinceitcombinesall study estimates into one single measure (for details, see [4] ). In addition, the varianceofthis estimate is readilyavailableas1/(w 1 +... +w k ). Though attractiveand simple,this approach is rarely appropriatei np ractice, sincet he assumption of homogeneity is oftenv iolated, and non-homogeneity or heterogeneity frequentlyoccurs .
3.3( Unobserved) Heterogeneity and the NonparametricMetaLikelihood
Effect-heterogeneity implies thatacertain value forthe effect is valid forsome studies whereas for others ad ifferent value is correct.Todemonstrate, it mightbethatthe heterogeneity consists in twos ubpopulations, whereo ne corresponds to am oderately harmful, the othertoamoreharmfuleffect, or,heterogeneity mightconsist out of three subpopulations, one corresponding to a harmful, the othert oabeneficial,a nd the third to an ull-effect.The latter example is particularlym isleading when as imple, weightedmean,which might takeonavalue near the null-effect,iscomputed.How can such as ituation be validlyc aptured by meanso famodel?T ypically, recenta pproaches concentrate on random effects models. These can be best illustratedasfollows.O ne supposes thatt he studies are sampled from ap opulation with an onhomogeneous effect pattern, in other words, there arean umber of components experiencing different sizes in the effect.One can thinkofadistribution P according to which sampling of studies takes place. It is no limitation to assume thatthis distribution is discretegiving mass p j to effect size λ j ,where j corresponds to the component in the population,j=1,..., m, wheremis the (unknown) number of components. It is assumed that the membership of each study to the associated subpopulationi su nknown.T he pair(λ^i , z i ) contains the observede ffect measure λ^i of the i-th study andt he unobserved indicator vector z i with exactly one 1inthe j-th position, say, indicating thatt he i-th study belongs to the j-th subpopulation. The corresponding unobserved meta-likelihood is (3) for which closed form solutions forp j and λ j exist. Unfortunately, z ij aren ot known, so thatt he marginal likelihood (margin over the latent variable) is appropriatetobe used:
This meta-likelihood is called observed and needst ob em aximized in the parameters λ 1, ..., λ m ,p 1 ,. .., p m .N ote there aren ow 2m -1p arameterss incet he non-negative weights p 1 ,...,p m aresumming up to 1. Note that if m=1t his meta-likelihood reduces to the oneg iven underh omogeneity. The unobserved meta-likelihood (3)and the observed meta-likelihood (4)a re connected by meansofamany-to-one mapping which maps the pair ( λ^i , z i )o nto λ^i .W eh avet hat unobserveda nd observedm eta-likelihood areconnected via (5) wherethe firstsummation is takeno verall possiblev ectors z i (for each it here are exactly mofthose) having asingle 1atone position. Ther esult (5)i so ne of the milestoneso ft he EM-algorithmic theory [ 12] . Estimationofthe 2m -1parameterscan be readilya ccomplishedw ith the EM algorithm.T he latter uses expected values e ij =E(Z ij | λ^i ; λ j ,p j )inthe unobserved metalikelihood (3)and maximization of this expected,u nobserved meta-likelihood provides newestimates for p j and λ j : (6) This is the M-step. It remains to provide the conditional expected valuese ij =E (Z ij | λ i; λ j ,p j ). Let Λ i be the random variablew ith realiziation λ i. Then / whereB ayes theorem wasu sed in the last equation.Therefore, we have (7) where ϕ is the standard normal density. This completesthe E-step.
TheE M-algorithm proceedsb yc ycling between steps(6) and(7). C.A.MAN,asoftware tool freelya vailablefrom the author's homepage can be used for computational practice. Details on the nonparametric mixture likelihood approach can be found in [11] . Note that thisa pproach modelst he background heterogeneitym ore completely thano thera pproaches liket he one by DerSimonianand Laird [13] in whichonly an adjustment of the varianceofthe overall effect estimator is provided.
In ourapproach we usethe model of unobservedheterogeneity as the starting point of allfurther analysis. We do thissincethe meta-likelihood foru nobservedh eterogeneityc an't be increased anyf urther for a givend atas et:i ti st he largest likelihood possiblea nd provides what is calledt he nonparametric maximum meta-likelihood (NPMML)and the corresponding estimator is calledthe nonparametric maximum meta-
likelihood estimator (NPMMLE). To avoid ap otential misunderstanding we point out that in the likelihood (5)mistreated as an unknown parameter. TheN PMML is the maximumm eta-likelihood fora ll possible valueso f λ 1, ..., λ m ,p 1 ,. .., p m , and m. The meta-likelihood is bounded over the set of alld iscretep robabilityd istributions on the real line,and,consequently, the NPMMLE exists.T his is in contrast to other normal likelihoodsw here restrictions need to be placed to attain boundedness of the likelihood (anexampleisthe mixtureofnormals with ac ommon unknown variancep arameter, wheret he likelihood increases beyond everyb ound when the numbero f components mi si ncreasing). Here,t hese problems do not exist, anda ne stimate mô f me xists whicha ssociates with the NPMMLE. Technically, using the EM algorithm thisestimate is foundinaconditional fashion,fixingt he mt ov alues1 ,2 ,3 ,… , andthenfinding estimateswith the EM algorithm for each value of m. Increasing mto (m +1 )i st erminatedw hent here is zero change in the associated likelihoods. Note thatthis is in contrast to other cases wherea likelihood increase is continuing for allincreases of m. Then NPMMLE(andwith this m^)c an also be computedw ith oneo ft he existing globals earch algorithmsl iket he vertex-exchange method [11] .
3.4I ncluding Covariates to Explain Heterogeneity
Having identifiedconsiderable unobserved heterogeneityt he question arises whether any observed variables can be associated with this latent form of heterogeneity. To put it in other words,one knows that there is heterogeneity,but it is yetunclearwhatitstands for.H aving observedf urther covariates, . This powerful tool is readilyavailableby meansofany statistical packagewhich can do weightedr egression. Here,t he package MINITAB [14] wasused.
3.5M odel Evaluation
Va rious models areconsideredand need to be evaluated in terms of whichm odelp rovidesthe most adequate explanation of the data. Fort he analysis provided here,t he Bayesian Information Criteria wasu sed throughout. It is defineda sB IC =2m etalog-likelihood -Nlog(k), where meta-loglikelihood standsf or the natural logarithm of the meta-likelihood of the model under consideration, Ns tandsf or the number of parameters involved in the model,a nd log(k) is the natural logarithm of the number of studies.The idea behind thiscriterion is thati fo ne adds morep arametersi nto the model the likelihood increases. It should therefore be penalized for the numbero f parameters involved in the model to balance the increase in fitwith the increased model complexity.T he BIC-criterion hast urned out to be avalid instrument fordiscriminating models. Fort he homogeneitym odel, N=1,sinceonlythe meanparameter is involved in the model.F or the heterogeneity model,there areN=2m -1parametersas mentioneda bove andf or the regression model N=p,the number of covariatesinthe model. Having includedall relevant covariates into the model one can expect that the log-likelihood forthe regression model becomesclosetothe log-likelihood forthe heterogeneitym odel, meaning that most of the residual heterogeneity hasb een explained. If thisis not the case, it can be expected thats ome additional covariate (yet unknown) needstobefound for explaining the residualheterogeneity.
3.6P ublication Bias
To avoid drawing unbiased conclusions from ameta-analysis it is important that all relevant primarys tudiesn eed to be identified on agiven subject. It hasbeen longacceptedt hatr esearch with statistically significant results is potentiallymore likely to be submitted,p ublished or published more rapidlythanw ork with null or non-significantresults,leading to incorrect,usually effect-overestimating conclusions. This problem is known as publication bias. Methods areavailablefor the diagnosis of publication biasi ncluding graphicalm ethods such as the funnelp lot [9] a nd statistical methods such as the rank correlation test [15] , Rosenthal's'file drawer'method [16] , the more recent'trim andfill' method [17] , or regression techniques.Adetailed discussion of thesetechniques can be found in [4, Ch. 7] . Thebasicideaofmostofthe techniques is based on the assumptiont hati ft here is no publication bias, thent he effect measure should be unrelatedtothe sample size. If the sample size of the study is not availablethe surrogate1/SEisused sinceitisknown that the standard error is inverselyrelated to the sample size. Though allo ft he abovem entioned methods have their moments,inthe approach here,w ef ocus on regression methods sincetheyallowthe unifying treatment of the subject. We followthe ideassuggested in Macaskill et al. [18] in whichthe effect measure λ^i is regressed on w i =1/ σ i 2 using weights w i . If there is no publication bias, then the regression to the inverse vari-Meta-Analysis: aUnifyingMeta-Likelihood Approach ances hould show no effect. Theb enefit of this approach is thati tc an be simultaneously included in the previouslymentioned regression approach for the covariates.
3.7S tudy Quality
Va rious methodological issues can influence the quality of as tudyi ncluding study design (cohort, unmatchedo r matchedc ase-control study,c ross-sectional), case andc ontrol selection, cohort group selection, case ande xposure assessment, andt he kind of statistical analysis (parametricm odelling or non-parametric estimation,logistic regression modelling or Mantel-Haenszel analysis). At best,none of thesefactors should be associated with the effect measure of interest.I th as been suggested [4] to combinet hese individual markersinto aquality scoreQS, andincorporate theses coresa sw eights intot he analysis. On the other hand,i ti so ftenr emarked critically thatt hese neww eights might incorporate new, subjective choices into the meta-analysis, sinced ifferent researchers dealing with the samebody of evidencem ightc ome up with very different weighing schemes. In fact,G reenland [19] hasindicated that quality assessmentisthe most insidious formofbiasinthe conductof meta-analysis. It seems to existageneral agreementt hataquality assessmento ft he primarystudiesshould be carriedout, possiblyu sing as cale, checklisto ri ndividual components,t hough there is controversy howt his should be incorporated at the analysis stage [20] . It is our opinion thatthe analysis should incorporate effectsd ue to study quality,i fa greementa bout study quality indicators can be reached.A n example for such an agreementwould be the fact if in astudyaneffect wasadjustedfor potential confounders or not; here most of the epidemiologists andstatisticians would agreethatitisv eryimportanttoadjust for potential confounders.
It is therefore suggested [4, Ch. 8] to use ar egression model in whicht he quality scoreisrelated to the effect measure.Here, we take up thisstraightforwardidea, butextend it to allowothercovariatesinthe model as well.
The ideacan be formalizedbyregressing the estimate of the effect measure onto the qualityscore ( λ^i on QS i ): (9) where ε i is anormal error with mean 0and variance σ i 2 ,and x i the vector of covariates alreadyi ncluded intot he modelling. Estimatescan againbefound using weightedregression.
It might be argued that theconstructionof the quality scoreisasubjective instrument itself, especially if it is notwell-acceptedin the area of research at hand. Then,insteadof using the quality scorei n( 9), one simply uses the original marker variables describing the quality of as tudy. This results in a model with twokindsofcovariate vectors: (10) wherei nc ontrast to (9) s i is the vector of study quality covariatesfor study i.
Reanalysisofthe MetaAnalysisbySillero-Arenas et al.[1]
We nowc ome back to the MA of SA and applythe ideasofsection 3. The homogeneity model showsconsiderabledifferenceto the heterogeneity model (see Table4) . Va rious models for heterogeneity have been estimated: modelsw ith m=2, m=3, and m=4subpopulations, the latter (m =4)corresponding to the NPMMLE. TheB ICvalue suggestsam odelw ith m=3c omponents (seeT able 4).Therefore, it can be expected thatc ovariatesa re to be found to explain the residualheterogeneity.W econsiders tudyt ype (case_control) andt he number of covariatesthathas been adjusted for in each study (Number-of-Covariates). When we includet he covariateso ne at a time,n one of them ares ignificant, though Case-Control and Number-of-Covariates areborderline (Table 3a) . When we include these twosimultaneouslythe latter becomes significant (seeT able 3b). This also corresponds to ac onsiderablea mount of increase in the log-likelihood.N ow,i ft he BIC-value of the regression model is comparedw ith the BIC-model of the heterogeneitymodel, it is seen thatthe regression model provides the better BIC-value.Thus, it can be arguedt hatm osto ft he heterogeneityi se xplained. Note that the covariate Numberofcovariates adjustedfor is transformedinto a0/1 covariate,indicating presence or absence of covariate adjustment in the original study.The basisf or thist ransformation is providedi nF igure 2w here there is almostn oc orrelation visible for largerv alueso ft he covariate (right hand side of the Fig. 2 ). 
4.1E stimatedAdjustedRelative Risk
Thee stimatedr elativer iska djustedf or study type andconfounding variables can be found using the equation logOR=-0.229 +0.356 number of covariates -0.104 case_control whichleadstoalog-odds ratio of 0.128with 95%C.I.of(0.002-0.255) when numberof covariates takes on the value 1a nd case_control the value 0. This corresponds to an OR of 1.137 with 95% CI of (1.002-1.291).
4.2P ublication Bias
Neither the funnel plot (provided in Fig. 3 ) nor the weightedregression (weights equal to the inversevariance) of the log-odds ratio onto the inversev ariance( weight) provide anye videncef or presence of ap ublication bias. SeeTable3cfor the regression output.
Study quality wasn ot further investigated, sincet he covariatesd escribingi t, namely study type and adjustment forc ovariates, have alreadyb een included into the model ,and have provedtoprovide an effect.Therefore, study quality hasinherently been takeninto the modelling.
Discussion
In summary,werefocus on our approach.It is assumedt hata ne ffect measure is available whichi sn ormallyd istributedw ith known study-specificv ariances. This assumptionisamereworking assumptionand could be replaced by somethingelsesuchas aB inomialo rP oisson distribution fort he measure of interest.Weare using the normal model to retain the simplicity of presentation.Inaddition, the normal model provides often reasonablea pproximationsf or effect measureslikeriskdifferences or risk ratios, if thosea re appropriatelyt ransformed. To identifyheterogeneity it is requiredtodoa mixture analysis in the firstp lace. If the Table 3 Regression output forweightedregression of log-odds-ratio on study type (case-control) andcovariateadjustment (numberofcovariates ajusted for) Meta-Analysis: aUnifyingMeta-Likelihood Approach meta-likelihood formodels of homogeneity andheterogeneity agree, no further analysis is necessary, sincethere is no heterogeneity to be explained. In thisc ase, one mayp roceed to the pooleda nalysis. Note thatt his implies as well thatthere is no need to check for publication biasn or study quality.I n mostcases, however, forms of heterogeneity might be found.These can be linked to study covariatesd escribings tudyc haracteristics, study quality or publication bias. Effect estimatesf or thesec ovariatesc an be simply found using weightedr egression ands ignificance of individual covariatesu sing Wald statisticswill lead to the finalmodel. Theideaisexpressed in Figure 4inacom pact way. Finally, having identified an appropriatem odelo ne can compare the associated likelihood with the likelihood for the unobservedheterogeneity.Ifboth likelihoodsa re close, thenm osto ft he heterogeneityhas been accounted for.Onthe other hand,ifthere is still considerabledisagreement between both likelihoods, the metaanalysis is still frail forexplaining residual heterogeneity, potentiallyb ym eanso fa missing covariate,c orrelateds tudies, or other causes of extra-heterogeneity.With regard to this aspect,t he MA could still be consideredincomplete.
Coming to the MA of HRTa nd breast cancer,itisarguedherethatthe overallresult of the meta-analysisb ySAwhich provided an odds ratioof1.062 with 95% confidencei nterval( 1.014-1.112) need to be corrected using up-to-date methods.Indeed, if we reconsider the meta-analysisb yS A andu se in as econdary analysis the tools availabletoday, we find an estimate of 1.137 on the relative risk scale indicating amore elevated risk for HRTthanthe one provided by SA. This finding occurs sincethe metaanalysis at hand experiences considerable unobserved heterogeneity, whichh as previouslyb een ignored.W ea rgue further in thiscontribution that thisformofheterogeneityc an be successfullyl inked to covariates observedinthe study base provided by SA, namelythe study type (cohortorcasecontrol) andw hether in the study the estimate of effect hasbeen adjustedfor potential confounders. It can be furthermoree stablishedt hatt hese covariatesd oi ndeed correlatewith the size of the effect measure. Consequently, an odds ratioa djustedf or study type andconfoundertreatment seems to be morea ppropriate, leading to the one givenabove.This effect estimate is morein the direction andc loser to the oneo f1 .26 provided in the WHI-trial [2] .
In general, it appearsa ppropriatea nd useful to include study characteristics( as well as patientc haracteristics) into the meta-analysis. Theanalysistools arereadily availablea nd easy to handle.The problem though might be that not allofthe interesting and important covariatesmightbeavailable.Therefore, it is supremelyimportantto incorporate unobservedh eterogeneity into the meta-likelihood,which can be used as an indicator for covariatesnot yetknown and/ or not yetincluded intothe meta-analysis. In the meta-analysisathandmostofthe unobservedh eterogeneity could be explained andt his can be taken as considerablee mpirical evidencefor the validity of the effect estimatesf ound with the modelling approach takenhere.
Furthermore,itwas investigated if these results could be prone to anyp ublication biaseffect.Using the graphicaldeviceofa funnelp lot in combination with an appropriater egression analysis no evidenceo fa presence of apublication biascould be detected.
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